<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zarifyan, Alla</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Fransen, Puck</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">MR CLEAN: TOR Affects Treatment Efficacy in Patients With Acute Ischemic Stroke</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-12</style></pages><abstract><style  face="normal" font="default" size="100%">An analysis of the MR CLEAN trial demonstrated a significant interaction between time from stroke onset to reperfusion and treatment effect, with the decrease in absolute risk difference between treated and untreated patients of almost 7% per hour (P = .038). The relationship between time to treatment and treatment effect was not statistically significant but is still considered biologically plausible.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>